Streptococcus bacteriophage (ATCC® 21597-B1)

Type Strain: no  /  Biosafety Level: 1

Deposited As Streptococcus phage
Application
Induction of lytic enzyme in Streptococcus sp. Group C
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Preceptrol® no
Type Strain no
Name of Depositor Chugai Pharm. Co., Ltd.
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Chain of Custody
ATCC <<--Chugai Pharm. Co., Ltd.<<--M. Yoshioka <<--- F. Egami <<--- W. Maxted
References

Ogawa H, et al. Method of production of anti-tumor substances. US Patent 3,786,141 dated Jan 15 1974

J. Biochem. 57: 64-74, 1965.